New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
Human Respiratory Syncytial Virus (hRSV) is one of the major causes of acute lower respiratory tract infections (ALRTI) worldwide, leading to significant levels of immunocompromisation as well as morbidity and mortality in infants. Its main target of infection is the ciliated epithelium of the lungs...
Main Authors: | Nicolás M. S. Gálvez, Jorge A. Soto, Alexis M. Kalergis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/8/1753 |
Similar Items
-
Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
by: Catalina A. Andrade, et al.
Published: (2020-06-01) -
Antibody development for preventing the human respiratory syncytial virus pathology
by: Jorge A. Soto, et al.
Published: (2020-04-01) -
Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
by: Jorge A. Soto, et al.
Published: (2018-12-01) -
Avaliação da atividade anti-hRSV da quercetina e seus derivados acetilados
by: Lopes, Bruno Rafael Pereira [UNESP]
Published: (2016) -
TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine
by: Emma Rey-Jurado, et al.
Published: (2020-02-01)